We are live on ! Find out more
ARNA

Arena Pharmaceuticals Inc
ARNA

Delisted

ARNA was delisted on the 10th of March, 2022.

Back to rankings

1 hedge funds and large institutions have $0 invested in Arena Pharmaceuticals Inc in 2022 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 312 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 316 → 1 (-315)

100% less funds holding in top 10

Funds holding in top 10: 7 → 0 (-7)

100% less capital invested

Capital invested by funds: $4.86B → $0 (-$4.86B)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 312

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
1
Holders Change
-315
Holders Change %
-99.68%
% of All Funds
0.02%
Holding in Top 10
–
Holding in Top 10 Change
-7
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
1
Closed
312
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
-$530M
2
BlackRock
BlackRock
New York
-$452M
3
Wellington Management Group
Wellington Management Group
Massachusetts
-$361M
4
State Street
State Street
Massachusetts
-$213M
5
Janus Henderson Group
Janus Henderson Group
United Kingdom
-$167M
Name Holding Trade Value Shares
Change 		Change in
Stake
PCH
126
Polar Capital Holdings
United Kingdom
– -$4.18K -44,930 Closed
Hudson Bay Capital Management
127
Hudson Bay Capital Management
Connecticut
– -$4.1M -44,091 Closed
SCM
128
Sio Capital Management
New York
– -$3.94M -42,379 Closed
Group One Trading
129
Group One Trading
Illinois
– -$3.93M -42,327 Closed
TAL
130
TIG Advisors LLC
New York
– -$3.87M -41,686 Closed
Invesco
131
Invesco
Georgia
– -$3.86M -41,516 Closed
CG
132
Cutler Group
California
– -$3.8M -40,913 Closed
SCM
133
Soleus Capital Management
Connecticut
– -$3.72M -40,000 Closed
WAM
134
Weiss Asset Management
Massachusetts
– -$3.72M -40,000 Closed
Marshall Wace
135
Marshall Wace
United Kingdom
– -$3.71M -39,846 Closed
Royal Bank of Canada
136
Royal Bank of Canada
Ontario, Canada
– -$3.53M -38,010 Closed
PAM
137
Panagora Asset Management
Massachusetts
– -$3.51M -37,795 Closed
SEC
138
Seven Eight Capital
New York
– -$3.46M -37,198 Closed
BNP Paribas Financial Markets
139
BNP Paribas Financial Markets
France
– -$3.42M -36,763 Closed
SEI Investments
140
SEI Investments
Pennsylvania
– -$3.23M -34,640 Closed
OAMG
141
Odey Asset Management Group
United Kingdom
– -$3.07M -33,000 Closed
AIG
142
American International Group
New York
– -$3.05M -32,837 Closed
Manulife (Manufacturers Life Insurance)
143
Manulife (Manufacturers Life Insurance)
Ontario, Canada
– -$2.9K -31,184 Closed
Capstone Investment Advisors
144
Capstone Investment Advisors
New York
– -$2.83M -30,419 Closed
LPL Financial
145
LPL Financial
California
– -$2.79M -30,003 Closed
HM
146
Harvest Management
New York
– -$2.79M -30,000 Closed
Bank of Montreal
147
Bank of Montreal
Ontario, Canada
– -$2.66M -28,534 Closed
Thrivent Financial for Lutherans
148
Thrivent Financial for Lutherans
Minnesota
– -$2.62M -28,221 Closed
Calamos Advisors
149
Calamos Advisors
Illinois
– -$2.51M -27,000 Closed
AQR Capital Management
150
AQR Capital Management
Connecticut
– -$2.5M -26,903 Closed
4 5
6
7 8

ARNA Hedge Fund Activity: Q1 2022 in Review

1 of the 6,341 institutional investors tracked by Wall St. Rank reported a position in Arena Pharmaceuticals Inc (ARNA) for Q1 2022, worth a combined $0 — down 100% from $4.86B a quarter earlier.

Sellers outnumbered buyers: 312 funds closed out of ARNA and 0 opened new positions — a net loss of 312 holders — while 1 trimmed existing stakes and 0 added.

The largest seller was Vanguard Group, exiting entirely with an estimated $530M sold.

  • 1 institutional investor held Arena Pharmaceuticals Inc (ARNA) as of Q1 2022, down from 316 in Q4 2021.
  • Funds reported $0 of Arena Pharmaceuticals Inc stock for Q1 2022, down 100% quarter-over-quarter.
  • 0 funds opened new Arena Pharmaceuticals Inc positions in Q1 2022 and 312 closed out, a net change of -312 holders.
  • The largest Arena Pharmaceuticals Inc seller in Q1 2022 was Vanguard Group, an estimated $530M sold.

Based on aggregated 13F filings for Q1 2022.